Although the abundance of cytokines, such as CCL18 and IL1b, in cancer cells may be responsible for initiating NF-kB signaling through activation of IKK in the CAF subset [41, 42], numerous feedback loops in the TME lead to the failure of therapeutic strategies to target inflammatory factors. This evidence concerns the gene IL1B and cancer.